The ANTHELSOL brand, founded in 1973 (Belgium), from 2466 sister brands and 17477 competing brands. ANTHELSOL is owned by JOHNSON & JOHNSON, listed on the stock exchange of New York ANTHELSOL is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(ANTHELSOL)
over 5 years*
USD 180.79